Memantine Alleviates Acute Lung Injury Via Inhibiting Macrophage Pyroptosis

Acute lung injury (ALI) is caused by direct pulmonary insults and indirect systemic inflammatory responses that result from conditions such as sepsis and trauma. Alveolar macrophages are the main and critical leukocytes in the airspace, and through the synthesis and release of various inflammatory mediators critically influence the development of ALI following infection and non-infectious stimuli. There is increasing recognition that inflammation and cell death reciprocally affect each other, which forms an auto-amplification loop of these two factors, and in turn, exaggerates inflammation. Therefore, pharmacological manipulation of alveolar macrophage death signals may serve as a logical therapeutic strategy for ALI. In this study, we demonstrate that memantine, a N-methyl-D-aspartic acid receptor (NMDAR) antagonist, through suppressing Ca2+ influx and subsequent ASC oligomerization inhibits macrophage Nlrp3 inflammasome activation and pyroptosis, therefore, alleviates ALI in septic mice. This finding explores a novel application of memantine, an FDA already approved medication, in the treatment of ALI, which is currently lacking effective therapy.

Automated summary

Acute lung injury (ALI) is caused by direct pulmonary insults and indirect systemic inflammatory responses. Alveolar macrophages play a critical role in ALI, influencing its development through the release of inflammatory mediators. Inflammation and cell death form an auto-amplification loop, exacerbating inflammation in ALI. Pharmacological manipulation of alveolar macrophage death signals may serve as a potential therapeutic strategy.